GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses

Brain Research Bulletin

Volumn 48, Issue 5, 1999, Pages 467-473

  Keverne, Eric B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

'Binding'; Developmental neurogenetics; Dopamine; Functional imaging; GABA ergic interneurons; Glutamate; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR;

DOPAMINERGIC NERVE CELL; HUMAN; INTERNEURON; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC NERVE;

ANIMALS; CEREBRAL CORTEX; GAMMA-AMINOBUTYRIC ACID; HUMANS; INTERNEURONS; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE; SCHIZOPHRENIA;

EID: 0033560003     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(99)00025-8     Document Type: Review

References (71)

1. Adams, B.; Moghaddam, B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J. Neurosci. 18:5545-5554; 1998.
2. Akbarian, S.; Kim, J. J.; Potkin, S. G.; Hagman, J. O.; Tafazzoli, A.; Bunney, W. E.; Jones, E. G. Gene-expression for glutamic-acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52:258-266; 1995.
3. Anderson, S. A.; Eisenstat, D. D.; Shi, L.; Rubenstein, J. L. R. Interneuron migration from basal forebrain to neocortex: Dependence on Dlx genes. Science 278:474-476; 1997.
4. Andreasen, N. C. Brain imaging: Applications in psychiatry. Science 239:1381-1388; 1988.
5. Barr, W. B.; Ashtari, M.; Bilder, R. M.; Degreef, G.; Lieberman, J. A. Brain morphometric comparison of first-episode schizophrenia and temporal lobe epilepsy. Br. J. Psychiatry 170:515-519; 1997.
6. Benes, F. M.; Vincent, S. L.; Marie, A.; Khan, Y. Up-regulation of GABA (A) receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 75:1021-1031; 1996.
7. Berman, K. F.; Weinberger, D. R. The prefrontal cortex in schizophrenia and other neuropsychiatric diseases: In vivo physiological correlates of cognitive deficits. In: Uylings, H. B. M.; Van Eden, C. G.; De Bruin, J. P. C.; Corner, M. A.; Freenstra, M. G. P., eds. Progress in brain research, vol. 85. Amsterdam: Elsevier Science; 1990:521-537.
8. Bosse, R.; Dipaolo, T. The modulation of brain dopamine and GABA(A) receptors by estradiol - a clue for CNS changes occurring at menopause. Cell. Mol. Neurobiol. 16:199-212; 1996.
9. Bredkjaer, S. R.; Mortensen, P. B.; Parnas, J. Epilepsy and non-organic non-affective psychosis. Br. J. Psychiatry 172:235-238; 1998.
10. Buzsáki, G.; Chrobak, J. J. Temporal structure in spatially organized neuronal ensembles: a role for interneuronal networks. Curr. Opin. Neurobiol. 5:504-510; 1995.
11. A receptor subunit genes. Psychiat. Genet. 5:23-29; 1995.
12. Cherubin, E.; Gaiarsa, J. L.; Ben-Ari, Y. GABA: An excitatory transmitter in early postnatal life. Trends Neurosci. 14:515-519; 1991.
13. DeLisi, L. E.; Sakuma, M.; Tew, W.; Hoff, A. L.; Grimson, R. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 74:129-140; 1995.
14. DelRio, M. R.; DeFelipe, J. Colocalization of parvalbumin and calbindin D-28k in neurons including chandelier cells of the human temporal neocrotex. J. Chem. Neuroanat. 12:165-173; 1997.
15. Done, D. J.; Johnstone, E. C.; Frith, C. D.; Golding, J.; Shepherd, P. M.; Crow, T. J. Complications of pregnancy and delivery in relation to psychosis in adult life: Data from the British perinatal mortality survey sample. Br. Med. J. 302:1576-1580; 1991.
16. Doward, D. M. General pharmacology of clozapine. Br. J. Psychiatry 170:5-11; 1992.
17. DSM, IV. Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: The American Psychiatric Association; 1994.
18. Fletcher, P. The missing link: A failure of fronto-hippocampal integration of schizophrenia. Nat. Neurosci. 1:266-267; 1998.
19. Frith, C. The role of the prefrontal cortex in self-consciousness: The case of auditory hallucinations. Phil. Trans. R. Soc. Lond. B 351:1505-1512; 1996.
20. Frith, C.; Dolan, R. J. Images of psychopathology. Curr. Opin. Neurobiol. 8:259-262; 1998.
21. Gilman, S.; Koeppe, R. A.; Adams, K.; Johnson-Greene, D.; Junck, L.; Kluin, K. J.; Mortorello, S.; Lohman, M. Positron emission tomographic studies of cerebral benzodiazepine receptor binding in chronic alcoholics. Ann. Neurol. 40:163-171; 1996.
22. Goodman, A. B. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc. Natl. Acad. Sci. USA 95:7249-7244; 1998.
23. Gray, C. M. Synchronous oscillations in neuronal systems: Mechanisms and functions. Comp. Neurosci. 1:11-38; 1994.
24. Gray, C. M.; König, P.; Engel, A. K.; Singer, W. Oscillatory responses in the cat visual cortex exhibit inter-columnar synchronization which reflects global stimulus properties. Nature 338:334-337; 1989.
25. Grobin, A. C.; Deutch, A. Y. Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat. J. Pharmacol. Exp. Ther. 285:350-357; 1998.
26. Guivarch, D.; Vernier, P.; Vincent, J. Sex steroid-hormones change the differential distribution of the isoforms of the D-2 dopamine-receptor messenger-RNA in the rat-brain. Neuroscience 69:159-166; 1995.
27. Harrison, P. J. Schizophrenia: A disorder of neurodevelopment? Curr. Opin. Neurobiol. 7:285-289; 1997.
28. 2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc. Natl. Acad. Sci. USA 95:735-740; 1998.
29. König, P.; Engel, A. K. Correlated firing in sensory-motor systems. Curr. Opin. Neurobiol. 5:511-519; 1995.
30. Laurent, G. Olfactory processing: Maps, time and codes. Curr. Opin. Neurobiol. 7:547-553; 1997.
31. Lawrie, S. M.; Abukmeil, S. S. Brain abnormality in schizophrenia. Br. J. Psychiatry 172:110-120; 1998.
32. Lidow, M. A.; Elsworth, J. D.; Goldman-Rakic, P. S. Down-regulation of the D1 and D4 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. J. Pharmacol. Exp. Ther. 281:597-603; 1997.
33. Lingford-Hughes, A. R.; Acton, P. D.; Gacinovic, S.; Suckling, J.; Busatton, G. F.; Boddington, J. A.; Bullmore, E.; Woodruff, P. W.; Costa, D. C.; Pilowsky, L. S.; Ell, P. J.; Marshall, E. J.; Derwin, R. W. Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. Br. J. Psychiatry 173:116-122; 1998.
34. LoTurco, J. J.; Owens, D. F.; Heath, M. J. S.; Davies, M. B. E.; Kriegstein, A. R. GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 15:1287-1298; 1995.
35. Ma, W.; Barker, J. L. Complementary expressions of transcripts encoding GAD(67) and GABA(A) receptor alpha 4, beta-1, and gamma-1 subunits in the proliferative zone of the embryonic rat central-nervous-system. J. Neurosci. 15:2547-2560; 1995.
36. Martinez, A.; Lubke, J.; Delrio, J. A.; Soriano, E.; Frotscher, M. Regional variability and postsynaptic targets of chandelier cells in the hippocampal-formation of the rat. J. Comp. Neurol. 376:28-44; 1996.
37. McInnes, L. A.; Reus, V. I.; Nelson, B. F. Mapping genes for psychiatric disorders and behavioral traits. Curr. Opin. Genet. Dev. 8:287-292; 1998.
38. McKonnell, S. K. Constructing the cerebral cortex: Neurogenesis and fate determination. Neuron 15:761-768; 1995.
39. Meltzer, H. Y. The importance of serotonin-dopamine interactions in the action of clozapine. Br. J. Psychiatry 160:22-29; 1992.
40. Mrzljak, L.; Bergson, C.; Pappy, M.; Huff, R.; Levenson, R.; Goldman-Rakic, P. S. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381:245-248; 1996.
41. Nestler, E. J. Under siege: The brain on opiates. Neuron 16:897-900; 1996.
42. Nguyen, Q.; Sapp, D. W.; Vaness, P. C.; Olsen, R. W. Modulation of GABA(A) receptor-binding in human brain by neuroactive steroids - species and brain regional differences. Synapse 19:77-87; 1995.
43. Nubassuabm, B. A.; Delorey, T. M.; Olsen, R. W.; Philippart, M.; Bronstein, Y.; Zhang, Q. W.; Guerrini, R.; VanNess, P.; Livet, M. O.; DelgadoEscueta, A. V. Angelman syndrome: Correlations between epilepsy phenotypes and genotypes. Ann. Neurol. 43:485-493; 1998.
44. Olney, J. W.; Farber, N. B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52:998-1007; 1995.
45. Olsen, R. W.; Venter, J. Benzodiazepine/GABA receptors and chloride channels: Structural and functional properties. New York: Alan R. Liss; 1986.
46. Pesold, C.; Impagnatiello, F.; Pisu, M. G.; Uzunov, D. P.; Costa, E.; Guidotti, A.; Caruncho, H. J. Reelin is preferentially expressed in neurons synthesizing γ-aminobutryric acid in cortex and hippocampus of adult rats. Proc. Natl. Acad. Sci. USA 95:3221-3226; 1998.
47. Rakic, P. Radial versus tangenital migration of neuronal clones in the developing cerebral cortex. Proc. Natl. Acad. Sci. USA 92:11323-11327; 1995.
48. Ritz, R.; Sejnowski, T. J. Synchronous oscillatory activity in sensory systems: New vistas of mechanisms. Curr. Opin. Neurobiol. 7:526-546; 1997.
49. Rubenstein, J. L. R.; Beachy, P. A. Patterning of the embryonic forebrain. Curr. Opin. Neurobiol. 8:18-26; 1998.
50. Sachdev, P. Schizophrenia-like psychosis and epilepsy: The status of the association. Am. J. Psychiatry 155:325-336; 1998.
51. Saigusa, T.; Takade, K.; Baker, S. C.; Kumar, R.; Stephenson, J. D. Dopamine efflux in the rat nucleus accumbens evoked by dopamine receptor stimulation in the entorhinal cortex is modulated by oestradiol and progesterone. Synapse 25:37-43; 1997.
52. SamsDodd, F. Effects of dopamine agonists and antagonists on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test. Psychopharmacology 135:182-193; 1998.
53. Shankle, W. R.; Romney, K. A.; Landings, B. H.; Hara, J. Developmental patterns in the cytoarchitecture of the human cerebral cortex from birth to 6 years examined by correspondence analysis. Proc. Natl. Acad. Sci. USA 95:4023-4028; 1998.
54. Sharma, T.; Lancaster, E.; Lee, D.; Lewis, S.; Sigmundsson, T.; Takei, N.; Gurling, H.; Barta, P.; Pearlson, G.; Murray, R. Volumetric MRI study of families multiply affected with schizophrenia - The Maudsley Family Study 5. Br. J. Psychiatry 173:132-138; 1998.
55. Singer, W.; Gray, C. M. Visual feature integration and the temporal correlation hypothesis. Annu. Rev. Neurosci. 18:555-586; 1995.
56. Somogyi, P.; Tamas, G.; Lujan, R.; Buhl, E. H. Salient features of synaptic organisation in the cerebral cortex. Brain Res. Rev. 26:113-135; 1998.
57. Steunpreis, R. E. The behavioral and neurochemical effects of phencyclidine in humans and animals: Some implications for modeling psychosis. Behav. Brain Res. 74:45-55; 1996.
58. Sunhara, R. K.; Seeman, P.; Van Tol, H. M.; Niz, H. B. Dopamine receptors and antipsychotic drug response. Br. J. Psychiatry 163:31-38; 1993.
59. Tamminga, C. A.; Holcomb, H. H.; Gao, X. M.; Lahti, A. C. Glutamate pharmacology and the treatment of schizophrenia: Current status and future directions. Int. Clin. Psychopharmacol. 10:29-37; 1995.
60. Terp, I. M.; Mortensens, P. B. Post-partum psychoses. Br. J. Psychiatry 172:521-526; 1998.
61. Vaadia, E.; Haalman, I.; Abeles, M.; Bergman, H.; Prut, Y.; Slovin, H.; Airtsen, A. M. H. J. Dynamics of neuronal interactions in monkey cortex in relation to behavioural events. Nature 373:515-518; 1995.
62. Volkow, N. D.; Wang, G.-J.; Fischman, M. W.; Foltin, R. W.; Fowler, J. S.; Abumrad, N. N.; Vitkun, S.; Logan, J.; Galley, S. J.; Pappas, N.; Hitzemann, R.; She, C. E. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386:827-830; 1997.
63. Vollenweider, F. X. Advances and pathophysiological models of hallucinogenic drug actions in humans: A preamble to schizophrenia research. Pharmacopsychiatry 31:92-103; 1998.
64. Vollenweider, F. X.; Leenders, K. L.; Oye, I.; Hell, D.; Angst, J. Differential psychopathology and patterns of cerebral glucose utilisation produced by (S) - and (R) - ketamine in healthy volunteers using positron emission tomography (PET). Eur. Neuropsychopharmacol. 7:25-38; 1997.
65. Vollenweider, F. X.; Leenders, K. L.; Scharfetter, C.; Antonini, A.; Maguire, P.; Missimer, J.; Angst, J. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomopgraphy (PET) and [F-18] fluorodeoxyglucose (FDG). Eur. Neuropsychopharmacol. 7:9-24; 1997.
66. von der Malsburg, C. Binding in models of perception and brain function. Curr. Opin. Neurobiol. 5:520-526; 1995.
67. A receptors: Com-parison in seizure-prone and -resistant mice and during development. J. Mol. Neurosci. 3:177-184; 1992.
68. Weinberger, D. R.; Berman, K. F. Prefrontal function in schizophrenia: Confounds and controversies. Phil. Trans. R. Soc. Lond. B 351:1495-1503; 1996.
69. Woo, T.-U.; Whitehead, R. E.; Melchitzky, D. S.; Lewis, D. A. A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl. Acad. Sci. USA 95:5341-5346; 1998.
70. Yoshida, M.; Yakoo, H.; Mizoguchi, K.; Tanaka, T.; Emoto, H.; Tanaka, M. NMDA- and MK801-induced changes in dopamine release are attenuated in kainic acid-lesioned nucleus accumbens of conscious rats: An in vivo microdialysis study. Brain Res. 786:226-229; 1998.
71. Yurgelun-Todd, D. A.; Waternaux, C. M.; Cohen, B. M.; Gruber, S. A.; English, C. D.; Renshaw, O. F. Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am. J. Psychiatry 153:200-205; 1996.